Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Barreras y facilitadores para una alimentación saludable y actividad física en mujeres embarazadas con sobrepeso y obesidad.

Orozco E, Pacheco S, Arredondo A, Torres C, Resendiz O.

Glob Health Promot. 2020 Feb 20:1757975920904701. doi: 10.1177/1757975920904701. [Epub ahead of print]

PMID:
32077376
2.

Pre-exposure prophylaxis and its implications in Mexico: notions of men who have sex with men.

Baruch R, Cuadra SM, Arellano J, Sánchez D, Ortega DV, Arredondo A.

Sex Health. 2020 Feb;17(1):22-28. doi: 10.1071/SH18193.

PMID:
31969247
3.

Ketamine and Treatment-Resistant Depression.

Lent JK, Arredondo A, Pugh MA, Austin PN.

AANA J. 2019 Oct;87(5):411-419.

PMID:
31612847
4.

Detection and expression analysis of tet(B) in Streptococcus oralis.

Arredondo A, Àlvarez G, Nart J, Mor C, Blanc V, León R.

J Oral Microbiol. 2019 Jul 23;11(1):1643204. doi: 10.1080/20002297.2019.1643204. eCollection 2019.

5.

Health Expenditures In China: Future Growth.

Arredondo A.

Health Aff (Millwood). 2019 Aug;38(8):1410-1411. doi: 10.1377/hlthaff.2019.00659. No abstract available.

PMID:
31381394
6.

New Coverage Schemes in Health, Income Level, Costs, and Use of Services in the Management of Hypertension.

Arredondo A, Recaman AL.

Am J Hypertens. 2019 Sep 24;32(10):932-934. doi: 10.1093/ajh/hpz109. No abstract available.

PMID:
31310272
7.

Azithromycin and erythromycin susceptibility and macrolide resistance genes in Prevotella from patients with periodontal disease.

Arredondo A, Blanc V, Mor C, Nart J, León R.

Oral Dis. 2019 Apr;25(3):860-867. doi: 10.1111/odi.13043. Epub 2019 Feb 7.

PMID:
30667163
8.

[Socioeconomic determinants of maternal obesity in Mexico and France. Comparative analysis of two cohorts].

Arredondo A, Torres C, Orozco E, Pacheco S, Aragón A, Huang F, Zambrano E, Bolaños-Jiménez F.

Rev Salud Publica (Bogota). 2018 Mar-Apr;20(2):245-253. doi: 10.15446/rsap.V20n2.72848. Spanish.

9.

Socio-economic indicators, dietary patterns, and physical activity as determinants of maternal obesity in middle-income countries: Evidences from a cohort study in Mexico.

Arredondo A, Torres C, Orozco E, Pacheco S, Huang F, Zambrano E, Bolaños-Jiménez F.

Int J Health Plann Manage. 2019 Jan;34(1):e713-e725. doi: 10.1002/hpm.2684. Epub 2018 Oct 23.

PMID:
30350426
10.

The IICR and the non-stationary structured coalescent: towards demographic inference with arbitrary changes in population structure.

Rodríguez W, Mazet O, Grusea S, Arredondo A, Corujo JM, Boitard S, Chikhi L.

Heredity (Edinb). 2018 Dec;121(6):663-678. doi: 10.1038/s41437-018-0148-0. Epub 2018 Oct 7.

11.

Challenges and dilemmas on universal coverage for non-communicable diseases in middle-income countries: evidence and lessons from Mexico.

Arredondo A, Azar A, Recaman AL.

Global Health. 2018 Aug 24;14(1):89. doi: 10.1186/s12992-018-0404-3.

12.

Determinants of Uncontrolled Hypertension in the Context of Universal Health Coverage in Middle-Income Countries.

Arredondo A, Recaman AL.

Am J Hypertens. 2018 Oct 15;31(11):1175-1177. doi: 10.1093/ajh/hpy124. No abstract available.

PMID:
30113624
13.

Trends and challenges in diabetes for middle-income countries: Evidence from Mexico.

Arredondo A, Orozco E, Duarte MB, Cuadra M, Recaman AL, Azar A.

Glob Public Health. 2018 Aug 1:1-14. doi: 10.1080/17441692.2018.1498115. [Epub ahead of print]

PMID:
30068257
14.

Challenges of health services related to the population displaced by violence in Mexico.

Duarte-Gómez MB, Cuadra-Hernández SM, Ruiz-Rodríguez M, Arredondo A, Cortés-Gil JD.

Rev Saude Publica. 2018 Jul 26;52:77. doi: 10.11606/S1518-8787.2018052017094. Review. English, Spanish.

15.

Stewardship and governance: structuring dimensions for Implementation Primary Health Care Policies in Paraguay, 2008-2017.

Cabral-Bejarano MS, Nigenda G, Arredondo A, Conill E.

Cien Saude Colet. 2018 Jul;23(7):2229-2238. doi: 10.1590/1413-81232018237.09242018. Spanish, English.

16.

Birth weight and social determinants in diabetes and hypertension.

Arredondo A.

J Diabetes. 2018 Nov;10(11):902-903. doi: 10.1111/1753-0407.12817. Epub 2018 Jul 24. No abstract available.

PMID:
29952073
17.

Diabetes duration, HbA1c, and cause-specific mortality in Mexico.

Arredondo A.

Lancet Diabetes Endocrinol. 2018 Jun;6(6):429-431. doi: 10.1016/S2213-8587(18)30098-6. Epub 2018 Mar 19. No abstract available.

18.

Challenges on the epidemiological and economic burden of diabetes and hypertension in Mexico.

Arredondo A, Orozco E, Alcalde-Rabanal J, Navarro J, Azar A.

Rev Saude Publica. 2018;52:23. doi: 10.11606/s1518-8787.2018052000293. Epub 2018 Feb 26. Spanish, English.

19.

Qualitative analysis of governance trends after health system reforms in Latin America: lessons from Mexico.

Arredondo A, Orozco E, Recaman AL.

Public Health. 2018 Mar;156:140-146. doi: 10.1016/j.puhe.2017.12.019. Epub 2018 Feb 20.

PMID:
29428577
20.

[Cost analyses of medical care for schizophrenia and depression in México, 2005-2013].

Arredondo A, Díaz-Castro L, Cabello-Rangel H, Arredondo P, Recaman AL.

Cad Saude Publica. 2018 Feb 5;34(1):e00165816. doi: 10.1590/0102-311X00165816. Spanish.

21.

Financial consequences from smoking-related diseases in middle-income countries: Evidence and lessons from Mexico.

Arredondo A, Recaman AL, Pinzon C, Azar A.

Int J Health Plann Manage. 2018 Apr;33(2):e454-e463. doi: 10.1002/hpm.2487. Epub 2018 Jan 24. No abstract available.

PMID:
29363795
22.

Challenges of the economic and social effects of diabetes in low- and middle-income countries.

Arredondo A, Azar A.

J Diabetes. 2018 Apr;10(4):344-345. doi: 10.1111/1753-0407.12633. Epub 2018 Jan 5. No abstract available.

PMID:
29206347
23.

The cost of diabetes in Latin America and the Caribbean in 2015: Evidence for decision and policy makers.

Barcelo A, Arredondo A, Gordillo-Tobar A, Segovia J, Qiang A.

J Glob Health. 2017 Dec;7(2):020410. doi: 10.7189/jogh.07.020410.

24.

Parent Preferences for Shared Decision-making in Acute Versus Chronic Illness.

Tom DM, Aquino C, Arredondo AR, Foster BA.

Hosp Pediatr. 2017 Oct;7(10):602-609. doi: 10.1542/hpeds.2017-0049.

25.

Decision-making Process by Users and Providers of Health Care Services During the AH1N1 Epidemic Influenza in Mexico: Lessons Learned and Challenges Ahead.

Huízar-Hernández V, Arredondo A, Caballero M, Castro-Ríos A, Flores-Hernández S, Pérez-Padilla R, Reyes-Morales H.

Arch Med Res. 2017 Apr;48(3):276-283. doi: 10.1016/j.arcmed.2017.06.007.

PMID:
28923330
26.

Diabetes, a global public health challenge with a high epidemiological and economic burden on health systems in Latin America.

Arredondo A, Azar A, Recamán AL.

Glob Public Health. 2018 Jul;13(7):780-787. doi: 10.1080/17441692.2017.1316414. Epub 2017 Apr 27.

PMID:
28447537
27.

Socioeconomic Determinants and Health Disparities in Relation to Hypertension in Middle-Income Countries.

Arredondo A, Recaman AL, Azar A.

Am J Hypertens. 2017 Apr;30(4):355-357. doi: 10.1093/ajh/hpx016. Epub 2017 Feb 11. No abstract available.

PMID:
28199506
28.

Neurobiological underpinnings and modulating factors in schizophrenia spectrum disorders with a comorbid substance use disorder: A systematic review.

Adan A, Arredondo AY, Capella MD, Prat G, Forero DA, Navarro JF.

Neurosci Biobehav Rev. 2017 Apr;75:361-377. doi: 10.1016/j.neubiorev.2017.01.038. Epub 2017 Feb 7. Review.

PMID:
28188887
29.

Governance and mental health: contributions for public policy approach.

Díaz-Castro L, Arredondo A, Pelcastre-Villafuerte BE, Hufty M.

Rev Saude Publica. 2017 Jan 30;51:4. doi: 10.1590/S1518-8787.2017051006991. Review. English, Spanish.

30.

Universal coverage and economic burden from epidemiological changes of diabetes in Latin America.

Arredondo A.

J Glob Health. 2016 Dec;6(2):020309. doi: 10.7189/jogh.06.020309. Review. No abstract available.

31.

Changing paradigms and challenges: evidence on the epidemiological and economic burden of diabetes in Latin America.

Arredondo A.

Diabet Med. 2017 Jul;34(7):1009-1010. doi: 10.1111/dme.13311. No abstract available.

PMID:
28004431
32.

Health Coverage for Undocumented Immigrants: Barriers on the Mexican Side for Effective Coverage.

Arredondo A.

Am J Public Health. 2016 Dec;106(12):e4-e5. No abstract available.

33.

[Indicators of governance in mental health policies and programmes in Mexico: a perspective of key actors].

Díaz-Castro L, Arredondo A, Pelcastre-Villafuerte BE, Hufty M.

Gac Sanit. 2017 Jul - Aug;31(4):305-312. doi: 10.1016/j.gaceta.2016.08.001. Epub 2016 Oct 21. Spanish.

34.

[Availability of indicators for monitoring the achievement of "Universal Health" in Latin America and the Caribbean].

Flórez CE, Chapman E, Panisset U, Arredondo A, Fitzgerald J, Reveiz L.

Rev Panam Salud Publica. 2016 Jun;39(6):330-340. Spanish.

PMID:
27706437
35.

Epidemiological and financial indicators of hypertension in older adults in Mexico: challenges for health planning and management in Latin America.

Arredondo A, Duarte MB, Cuadra SM.

Int J Health Plann Manage. 2017 Apr;32(2):e121-e136. doi: 10.1002/hpm.2362. Epub 2016 May 30.

PMID:
27238949
36.

Healthcare Costs in Older Adults with Diabetes Mellitus: Challenges for Health Systems and for Society.

Arredondo A, Aviles R.

J Am Geriatr Soc. 2015 Nov;63(11):2421-3. doi: 10.1111/jgs.13813. No abstract available.

PMID:
26603071
37.

Challenges of the epidemiological and economic burdens associated with hypertension in middle income countries: evidence from Mexico.

Arredondo A, Cuadra SM, Duarte MB.

BMC Public Health. 2015 Nov 6;15:1106. doi: 10.1186/s12889-015-2430-x.

38.

Health Disparities in and Transdisciplinary Approach to Cardiovascular Disease in Mexico.

Arredondo A, Avilés R.

Am J Public Health. 2015 Oct;105(10):e3-4. doi: 10.2105/AJPH.2015.302824. Epub 2015 Aug 13. No abstract available.

39.

Positioning new pharmacotherapies for COPD.

Barjaktarevic IZ, Arredondo AF, Cooper CB.

Int J Chron Obstruct Pulmon Dis. 2015 Jul 24;10:1427-42. doi: 10.2147/COPD.S83758. eCollection 2015. Review.

40.

Periodontal pathogens and tetracycline resistance genes in subgingival biofilm of periodontally healthy and diseased Dominican adults.

Collins JR, Arredondo A, Roa A, Valdez Y, León R, Blanc V.

Clin Oral Investig. 2016 Mar;20(2):349-56. doi: 10.1007/s00784-015-1516-2. Epub 2015 Jun 30.

41.

Costs and epidemiological changes of chronic diseases: implications and challenges for health systems.

Arredondo A, Aviles R.

PLoS One. 2015 Mar 17;10(3):e0118611. doi: 10.1371/journal.pone.0118611. eCollection 2015.

42.
43.

Lung cancer screening, targeted temperature after cardiac arrest, and vasopressin and steroids in cardiac arrest.

Hwang JY, Arredondo AF, Paul TK.

Am J Respir Crit Care Med. 2014 Apr 15;189(8):994-5. doi: 10.1164/rccm.201401-0133RR. No abstract available.

PMID:
24735033
44.

Hypertension and its effects on the economy of the health system for patients and society: suggestions for developing countries.

Arredondo A, Avilés R.

Am J Hypertens. 2014 Apr;27(4):635-6. doi: 10.1093/ajh/hpu010. Epub 2014 Mar 8. No abstract available.

PMID:
24610899
45.

10x10 comes full circle: Spanish version back to United States in Puerto Rico.

Margolis A, Joglar F, de Quirós FG, Baum A, Fernández A, García S, Arredondo AL, Hersh WR.

Stud Health Technol Inform. 2013;192:1134.

PMID:
23920908
46.

Health disparities from economic burden of diabetes in middle-income countries: evidence from México.

Arredondo A, Reyes G.

PLoS One. 2013 Jul 12;8(7):e68443. doi: 10.1371/journal.pone.0068443. Print 2013.

47.

Diabetes in Mexico: cost and management of diabetes and its complications and challenges for health policy.

Barquera S, Campos-Nonato I, Aguilar-Salinas C, Lopez-Ridaura R, Arredondo A, Rivera-Dommarco J.

Global Health. 2013 Feb 2;9:3. doi: 10.1186/1744-8603-9-3. Review.

48.

Improving access to health care for undocumented immigrants in the United States.

Wallace SP, Rodriguez M, Padilla-Frausto I, Arredondo A, Orozco E.

Salud Publica Mex. 2013;55 Suppl 4:S508-14.

PMID:
25153191
49.

Diabetes: a global challenge with high economic burden for public health systems and society.

Arredondo A.

Am J Public Health. 2013 Feb;103(2):e1-2. doi: 10.2105/AJPH.2012.301106. Epub 2012 Dec 13. No abstract available.

50.

[Towards a transdisciplinary approach and social determinants for the study of infant mortality].

Arredondo A.

Cad Saude Publica. 2012 Sep;28(9):1807-8; author reply 1808-10. Spanish. No abstract available.

Supplemental Content

Loading ...
Support Center